Evidence map›Paper›PMID 24677029›Full record

ArticleMolecular & cellular proteomics : MCP2014

Numerical compression schemes for proteomics mass spectrometry data.

Johan Teleman, Andrew W Dowsey, Faviel F Gonzalez-Galarza, Simon Perkins, Brian Pratt, Hannes L Röst, Lars Malmström, Johan Malmström, Andrew R Jones, Eric W Deutsch and 1 more

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Johan TelemanFrom the ‡Department of Immunotechnology, Lund University, Medicon Village building 406, 223 81 Lund Sweden;
Andrew W Dowsey§Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, United Kingdom; ¶Centre for Advanced Discovery and Experimental Therapeutics (CADET), University of Manchester and Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Oxford Road, Manchester M13 9WL, United Kingdom;
Faviel F Gonzalez-Galarza‖Institute of Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, United Kingdom;
Simon Perkins‖Institute of Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, United Kingdom;
Brian Pratt**Department of Genome Sciences, University of Washington School of Medicine, Seattle, Washington, 98195, USA;
Hannes L Röst‡‡Department of Biology, Institute of Molecular Systems Biology, Eidgenössische Technische Hochschule Zürich, Wolfgang-Pauli Strasse 16, 8093 Zurich, Switzerland;
Lars Malmström‡‡Department of Biology, Institute of Molecular Systems Biology, Eidgenössische Technische Hochschule Zürich, Wolfgang-Pauli Strasse 16, 8093 Zurich, Switzerland;
Johan Malmström§§Department of Clinical Sciences, Faculty of Medicine, Lund University, SE-221 84 Lund, Sweden;
Andrew R Jones‖Institute of Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, United Kingdom;
Eric W Deutsch¶¶Institute for Systems Biology, 401 Terry Avenue North, Seattle, Washington 98109, USA; edeutsch@systemsbiology.org.
Fredrik LevanderFrom the ‡Department of Immunotechnology, Lund University, Medicon Village building 406, 223 81 Lund Sweden; ‖‖Bioinformatics Infrastructure for Life Sciences, Lund University, Sweden.

Funding

Shortening the development cycle time of Trans Proteomic Pipeline tools with high performance computingR01GM087221 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI DEUTSCH, ERIC, MORITZ, ROBERT L · 2010 to 2021
$6.0M
Complete Human Peptide- and MRM-AtlasRC2HG005805 · NHGRI · INSTITUTE FOR SYSTEMS BIOLOGY · PI HOOD, LEROY E, MORITZ, ROBERT L · 2009 to 2010
$4.6M
Biotechnology and Biological Sciences Research Council BB/I00095X/1Biotechnology and Biological Sciences Research Council BB/K016733/1Biotechnology and Biological Sciences Research Council BB/K01997X/1Biotechnology and Biological Sciences Research Council R01GM087221European Research Council 309831NHGRI NIH HHS RC2 HG005805NHGRI NIH HHS RC2HG005805NIGMS NIH HHS R01 GM087221
6 · The paper itself

Abstract

The open XML format mzML, used for representation of MS data, is pivotal for the development of platform-independent MS analysis software. Although conversion from vendor formats to mzML must take place on a platform on which the vendor libraries are available (i.e. Windows), once mzML files have been generated, they can be used on any platform. However, the mzML format has turned out to be less efficient than vendor formats. In many cases, the naïve mzML representation is fourfold or even up to 18-fold larger compared with the original vendor file. In disk I/O limited setups, a larger data file also leads to longer processing times, which is a problem given the data production rates of modern mass spectrometers. In an attempt to reduce this problem, we here present a family of numerical compression algorithms called MS-Numpress, intended for efficient compression of MS data. To facilitate ease of adoption, the algorithms target the binary data in the mzML standard, and support in main proteomics tools is already available. Using a test set of 10 representative MS data files we demonstrate typical file size decreases of 90% when combined with traditional compression, as well as read time decreases of up to 50%. It is envisaged that these improvements will be beneficial for data handling within the MS community.

Indexed as

Mass SpectrometryProteomicsSoftwareAlgorithmsDatabases, ProteinNumerical Analysis, Computer-Assisted

Identifiers

PMID24677029
PMCPMC4047472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.